Baguinda, Mark Daniel A.

HRN: 28-62-91  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
03/03/2026
03/07/2026
ORAL
3ml
OD
PCAP-C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines